EUVIMED · CrossrefZeitschrift
Journal of Neural Transmission
ISSN 0300-9564 · Springer Science and Business Media LLC
Neueste Artikel
The effect of levodopa on non-motor symptoms in Parkinson’s disease: the good, the bad and the ugly
AlcoRhythm vs. algorithm: Is a stepped approach to Parkinson’s therapy still sensible?
How to determine the suitability of Parkinson’s disease patients for device-aided therapies: a practical approach
The CheckBRAIN™ platform: architecture for post-screening brain health care across the Parkinson’s disease continuum
Clinical correlates of cognitive impairment in progressive supranuclear palsy and multiple system atrophy: a comparative neuropsychological study
Neutrophil-to-lymphocyte ratio predicts infusion-site skin nodules in Parkinson’s disease patients receiving foslevodopa/foscarbidopa subcutaneous infusion
Peripheral α-Synuclein oligomer accumulation in MAPT p.D750V–associated autosomal-dominant parkinsonism: evidence from in vivo skin biopsies
Subcutaneous apomorphine and the nonmotor features of Parkinson’s disease
Age-dependent subcortical iron accumulation in chronic schizophrenia: findings from a quantitative susceptibility mapping study
The future digital outpatient clinic for movement disorders: from technological innovation to ethical and systemic implementation—a position paper
Dysphagia and gastrointestinal disorders in Parkinson’s disease: towards a diagnostic standard operating procedure for the interprofessional neurological outpatient care team
Why dopamine replacement therapy will stay as a cornerstone in the treatment of Parkinson disease: a personal opinion
The German Parkinson expert meetings
Sublingual apomorphine for Parkinsonian tremor: a post-hoc analysis of pivotal trial data
Population pharmacokinetic analyses comparing immediate-release levodopa/carbidopa, controlled-release levodopa/carbidopa, and IPX203. Findings from a phase 1 study in healthy volunteers
Multiple system atrophy: cure and care
Toward the prevention of clinically manifest Parkinson’s disease
Quality management and specifications of multidisciplinary Parkinson’s disease management: an expert opinion
Not always the usual suspect: symptom variations in Parkinson’s disease beyond ON-OFF fluctuations
German Delphi consensus: COMT inhibitors in the management of wearing-off fluctuations in Parkinson’s disease
On-demand therapies–emergency medication or daily routine?
Early clinical experience with IPX203 in Parkinson’s disease with motor fluctuations
Twenty-five years of progress in Parkinson’s disease research: from dopamine replacement to biological definition and regenerative therapy
Improving the clinical trial landscape for Parkinson syndromes in Germany
Single ayahuasca administration mitigates long-term behavioral and neurochemical effects of early-life stress in rats
Cross-sectional and longitudinal validation of short and long versions of the progressive supranuclear palsy quality of life scale
HDL cholesterol indicates neurodegenerative vulnerability in dementia with lewy bodies
Remote smartphone-based spoken language screening predicts clinical markers in Huntington’s disease
Prevalence and state-dependent patterns of non-motor fluctuations in Parkinson’s disease
What’s in a name? reframing advanced Parkinson’s disease as a multidimensional state
Jahrgänge
2026 · 2372025 · 1952024 · 1352023 · 1342022 · 1372021 · 1602020 · 1602019 · 1542018 · 1632017 · 1682016 · 1602015 · 1992014 · 1642013 · 2122012 · 1752011 · 1912010 · 1672009 · 1952008 · 1992007 · 2172006 · 1862005 · 1462004 · 1202003 · 1162002 · 1302001 · 1242000 · 1241999 · 1001998 · 1041997 · 1301996 · 1381995 · 931994 · 961993 · 931992 · 991991 · 1031990 · 961989 · 1001988 · 961987 · 87
EUVIMED